Format
Sort by

Send to

Choose Destination

Links from Protein

Items: 1 to 20 of 58

1.

Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells.

Alberti L, Losi L, Leyvraz S, Benhattar J.

PLoS One. 2015 Jul 17;10(7):e0132977. doi: 10.1371/journal.pone.0132977.

2.

Hypomethylation of the CTCFL/BORIS promoter and aberrant expression during endometrial cancer progression suggests a role as an Epi-driver gene.

Hoivik EA, Kusonmano K, Halle MK, Berg A, Wik E, Werner HM, Petersen K, Oyan AM, Kalland KH, Krakstad C, Trovik J, Widschwendter M, Salvesen HB.

Oncotarget. 2014 Feb 28;5(4):1052-61.

3.

Possible prognostic value of BORIS transcript variants ratio in laryngeal squamous cell carcinomas - a pilot study.

Novak Kujundžić R, Grbeša I, Ivkić M, Krušlin B, Konjevoda P, Gall Trošelj K.

Pathol Oncol Res. 2014 Jul;20(3):687-95. doi: 10.1007/s12253-014-9749-y.

PMID:
24563233
4.

BORIS/CTCFL is an RNA-binding protein that associates with polysomes.

Ogunkolade BW, Jones TA, Aarum J, Szary J, Owen N, Ottaviani D, Mumin MA, Patel S, Pieri CA, Silver AR, Sheer D.

BMC Cell Biol. 2013 Nov 26;14:52. doi: 10.1186/1471-2121-14-52.

5.

Expression of the cancer-testis antigen BORIS correlates with prostate cancer.

Cheema Z, Hari-Gupta Y, Kita GX, Farrar D, Seddon I, Corr J, Klenova E.

Prostate. 2014 Feb;74(2):164-76. doi: 10.1002/pros.22738.

PMID:
24123052
6.
7.

Cancer-testis antigen BORIS is a novel prognostic marker for patients with esophageal cancer.

Okabayashi K, Fujita T, Miyazaki J, Okada T, Iwata T, Hirao N, Noji S, Tsukamoto N, Goshima N, Hasegawa H, Takeuchi H, Ueda M, Kitagawa Y, Kawakami Y.

Cancer Sci. 2012 Sep;103(9):1617-24. doi: 10.1111/j.1349-7006.2012.02355.x.

8.

Expression of the epigenetic factor BORIS (CTCFL) in the human genome.

de Necochea-Campion R, Ghochikyan A, Josephs SF, Zacharias S, Woods E, Karimi-Busheri F, Alexandrescu DT, Chen CS, Agadjanyan MG, Carrier E.

J Transl Med. 2011 Dec 14;9:213. doi: 10.1186/1479-5876-9-213. Review.

9.

BORIS binding to the promoters of cancer testis antigens, MAGEA2, MAGEA3, and MAGEA4, is associated with their transcriptional activation in lung cancer.

Bhan S, Negi SS, Shao C, Glazer CA, Chuang A, Gaykalova DA, Sun W, Sidransky D, Ha PK, Califano JA.

Clin Cancer Res. 2011 Jul 1;17(13):4267-76. doi: 10.1158/1078-0432.CCR-11-0653.

10.

Analysis of promoter methylation and polymorphic minisatellites of BORIS and lack of association with gastric cancer.

Yoon SL, Roh YG, Lee SH, Kim SH, Kim MC, Kim SJ, Leem SH.

DNA Cell Biol. 2011 Sep;30(9):691-8. doi: 10.1089/dna.2011.1248.

PMID:
21495859
11.

The structural complexity of the human BORIS gene in gametogenesis and cancer.

Pugacheva EM, Suzuki T, Pack SD, Kosaka-Suzuki N, Yoon J, Vostrov AA, Barsov E, Strunnikov AV, Morse HC 3rd, Loukinov D, Lobanenkov V.

PLoS One. 2010 Nov 8;5(11):e13872. doi: 10.1371/journal.pone.0013872.

12.

Susceptibility for breast cancer in young patients with short rare minisatellite alleles of BORIS.

Yoon SL, Kim DC, Cho SH, Lee SY, Chu IS, Heo J, Leem SH.

BMB Rep. 2010 Oct;43(10):698-703. doi: 10.5483/BMBRep.2010.43.10.698.

13.

BORIS/CTCFL expression is insufficient for cancer-germline antigen gene expression and DNA hypomethylation in ovarian cell lines.

Woloszynska-Read A, James SR, Song C, Jin B, Odunsi K, Karpf AR.

Cancer Immun. 2010 Jul 23;10:6.

14.

Molecular architecture of CTCFL.

Campbell AE, Martinez SR, Miranda JJ.

Biochem Biophys Res Commun. 2010 Jun 4;396(3):648-50. doi: 10.1016/j.bbrc.2010.04.146.

15.

BORIS (CTCFL) is not expressed in most human breast cell lines and high grade breast carcinomas.

Hines WC, Bazarov AV, Mukhopadhyay R, Yaswen P.

PLoS One. 2010 Mar 17;5(3):e9738. doi: 10.1371/journal.pone.0009738.

16.

BORIS, a paralogue of the transcription factor, CTCF, is aberrantly expressed in breast tumours.

D'Arcy V, Pore N, Docquier F, Abdullaev ZK, Chernukhin I, Kita GX, Rai S, Smart M, Farrar D, Pack S, Lobanenkov V, Klenova E.

Br J Cancer. 2008 Feb 12;98(3):571-9. doi: 10.1038/sj.bjc.6604181. Erratum in: Br J Cancer. 2008 Feb 12;98(3):676.

17.
18.

Expression of BORIS in melanoma: lack of association with MAGE-A1 activation.

Kholmanskikh O, Loriot A, Brasseur F, De Plaen E, De Smet C.

Int J Cancer. 2008 Feb 15;122(4):777-84.

19.

[Preparation of the monoclonal antibodies against human BORIS and the expression pattern of BORIS in normal and diseased human mammary tissues].

Zhou XC, Song CJ, Wang X, Tian Y, Jin BQ.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2007 Apr;23(4):353-5. Chinese.

PMID:
17428394
20.

Global expression analysis of cancer/testis genes in uterine cancers reveals a high incidence of BORIS expression.

Risinger JI, Chandramouli GV, Maxwell GL, Custer M, Pack S, Loukinov D, Aprelikova O, Litzi T, Schrump DS, Murphy SK, Berchuck A, Lobanenkov V, Barrett JC.

Clin Cancer Res. 2007 Mar 15;13(6):1713-9.

Items per page

Supplemental Content

Support Center